QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.108.143339v1 327/2/432    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Knütter, I. Articles by Brandsch, M. Search for Related Content PubMed PubMed Citation Articles by Knütter, I. Articles by Brandsch, M.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Transport of Angiotensin-Converting Enzyme Inhibitors by H⁺/Peptide Transporters Revisited

Membrane Transport Group, Biozentrum, Martin-Luther-University Halle-Wittenberg, Halle, Germany (I.K., C.W., M.G.H., W.F., K.Z., M.B.); Molecular Nutrition Unit, Center of Life and Food Science, Technical University of Munich, Munich, Germany (G.K., H.D.); and Institute of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle, Germany (R.H.H.N.)

Angiotensin-converting enzyme (ACE) inhibitors are often regarded as substrates for the H⁺/peptide transporters (PEPT)1 and PEPT2. Even though the conclusions drawn from published data are quite inconsistent, in most review articles PEPT1 is claimed to mediate the intestinal absorption of ACE inhibitors and thus to determine their oral availability. We systematically investigated the interaction of a series of ACE inhibitors with PEPT1 and PEPT2. First, we studied the effect of 14 ACE inhibitors including new drugs on the uptake of the dipeptide [¹⁴C]glycylsarcosine into human intestinal Caco-2 cells constitutively expressing PEPT1 and rat renal SKPT cells expressing PEPT2. In a second approach, the interaction of ACE inhibitors with heterologously expressed human PEPT1 and PEPT2 was determined. In both assay systems, zofenopril and fosinopril were found to have very high affinity for binding to peptide transporters. Medium to low affinity for transporter interaction was found for benazepril, quinapril, trandolapril, spirapril, cilazapril, ramipril, moexipril, quinaprilat, and perindopril. For enalapril, lisinopril, and captopril, very weak affinity or lack of interaction was found. Transport currents of PEPT1 and PEPT2 expressed in Xenopus laevis oocytes were recorded by the two-electrode voltage-clamp technique. Statistically significant, but very low currents were only observed for lisinopril, enalapril, quinapril, and benazepril at PEPT1 and for spirapril at PEPT2. For the other ACE inhibitors, electrogenic transport activity was extremely low or not measurable at all. The present results suggest that peptide transporters do not control intestinal absorption and renal reabsorption of ACE inhibitors.

Address correspondence to: Dr. Matthias Brandsch, Biozentrum of the Martin-Luther-University Halle-Wittenberg, Membrane Transport Group, Weinbergweg 22, D-06120 Halle, Germany. E-mail: matthias.brandsch{at}biozentrum.uni-halle.de